Clinical Trials Browser

atezolizumab × Endocrine × 30 days × Clear all

NCT05470595 2026-04-15

LCNEC-ALPINE

Phase 2 Active not recruiting

EndocrineThoracic

Lung Neoplasms, Carcinoma, Neuroendocrine